• 1

    Kumar MJ, Gowda N: Maduramycosis of foot: a case report of Boyd's amputation as a salvage procedure in late presentation. Foot Ankle Online J 4: 2, 2011.

    • Search Google Scholar
    • Export Citation
  • 2

    Jones JW, Alden HS: Maduromycotic mycetoma (Madura foot): report of a case occurring in an American Negro. JAMA 96: 256, 1931.

  • 3

    Welsh O, Al-Abdely HM, Salinas-Carmona MC, et al: Mycetoma medical therapy. PLoS Negl Trop Dis 8: e3218, 2014.

  • 4

    Lopez-Martinez R, Mendez-Tovar LJ, Bonifaz A, et al: Update on the epidemiology of mycetoma in Mexico. A review of 3933 cases. Gac Med Mex 149: 586, 2013.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Bonifaz A, Tirado-Sánchez A, Calderón L, et al: Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis 8: e3102, 2014.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Gomez-Flores A, Welsh O, Said-Fernandez S, et al: In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 48: 832, 2004.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Vera-Cabrera L, Campos-Rivera MP, Escalante-Fuentes WG, et al: In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid. Antimicrob Agents Chemother 54: 2191, 2010.

    • Crossref
    • Web of Science
    • Search Google Scholar
    • Export Citation
  • 8

    De Sarro A, La Camera E, Fera MT: New and investigational triazole agents for the treatment of invasive fungal infections. J Chemother 20: 661, 2008.

    • Crossref
    • PubMed
    • Web of Science
    • Search Google Scholar
    • Export Citation
  • 9

    US Food and Drug Administration: Postmarket drug safety information for patients and providers. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm371019.htm. Accessed November 15, 2016.

    • Search Google Scholar
    • Export Citation
  • 10

    N'Diaye B, Dieng MT, Perez A, et al: Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45: 154, 2006.

  • 11

    Hay RJ, Mackenzie DWR: Mycetoma (madura foot) in the United Kingdom—a survey of forty-four cases. Clin Exp Dermatol 8: 553, 1983.

  • 12

    White EA, Patel DB, Forrester DM, et al: Madura foot: two case reports, review of the literature, and new developments with clinical correlation. Skeletal Radiol 43: 547, 2014.

    • Crossref
    • PubMed
    • Web of Science
    • Search Google Scholar
    • Export Citation

Pedal Fungal Mass in the Midwest

Sarah N. Standish St. Vincent Hospital Indianapolis, Indianapolis, IN.

Search for other papers by Sarah N. Standish in
Current site
Google Scholar
PubMed
Close
 DPM
,
Wendy Goldstein St. Vincent Hospital Indianapolis, Indianapolis, IN.

Search for other papers by Wendy Goldstein in
Current site
Google Scholar
PubMed
Close
 DPM
, and
Chase R. Stuart St. Vincent Hospital Indianapolis, Indianapolis, IN.

Search for other papers by Chase R. Stuart in
Current site
Google Scholar
PubMed
Close
 DPM
Restricted access

Mycetoma cases are predominantly found in tropical regions and are a rare finding in the United States. These masses that are fungal or bacterial in origin can result in significant destruction of soft tissue and bone. We present a case of a patient who emigrated from Mexico to Indianapolis. He presented with a soft-tissue mass that was excised and ultimately found to be a eumycetoma of the hallux of his left foot. Successful treatment included surgical resection in combination with postoperative terbinafine, which was pulse dosed to decrease its impact on hepatic function.

Corresponding author: Wendy Goldstein, DPM, St. Vincent Hospital Indianapolis, 2001 W 86th St, Indianapolis, IN 46260. (E-mail: wgoldstein.dpm@gmail.com)